Episode Details

In this episode, we explore whether high-dose olanzapine — beyond the FDA-approved 20 mg ceiling — can be a viable strategy for patients with treatment-resistant schizophrenia when clozapine isn't yet an option. Can pushing the dose bridge the gap between partial response and full remission?

Faculty: Oliver Freudenreich, M.D.
Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.75 CME: Quick Take Vol. 83
• Treatment-Resistant Schizophrenia: Should You Consider High-Dose Olanzapine Instead of Clozapine?